MedTrace Logo

Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation

NCT02950285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2336

Last updated 2017-06-14

No results posted yet for this study

Summary

The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts General Hospital (MGH) of their patients with AF and elevated stroke risk that are not taking an anticoagulant for stroke prevention. The investigators hypothesize that interventions to notify physicians of such individuals may prompt reassessment for the need for anticoagulation, and thereby increase guideline-indicated anticoagulation rates. Additionally, in a survey component, physicians will characterize reasons for not pursuing anticoagulation in AF patients at elevated risk for stroke.

Conditions

Interventions

OTHER

Baseline alert

PCP notification at baseline that patient has atrial fibrillation, high stroke risk, and is not anticoagulated.

Sponsors & Collaborators

Principal Investigators

  • Steven A Lubitz, MD, MPH · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-07
Primary Completion
2017-05-07
Completion
2017-05-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950285 on ClinicalTrials.gov